| Eckmann DM, Wood HC
Polidocanol for endovenous microfoam sclerosant therapy. [JOURNAL ARTICLE]
Expert Opin Investig Drugs 2009 Nov 16.
Abstract | Full Citation | Find Related Articles |
| Bhargava A, Vaishampayan UN
Satraplatin: leading the new generation of oral platinum agents. [Journal Article]
Expert Opin Investig Drugs 2009 Nov; 18(11):1787-97.
Abstract | Full Citation |
| Kümmerle T, Lehmann C, Hartmann P, et al.
Vicriviroc: a CCR5 antagonist for treatment-experienced patients with HIV-1 infection. [Journal Article]
Expert Opin Investig Drugs 2009 Nov; 18(11):1773-85.
Abstract | Full Citation | Find Related Articles |
| Pinna A
Novel investigational adenosine A(2A) receptor antagonists for Parkinson's disease. [Journal Article]
Expert Opin Investig Drugs 2009 Nov; 18(11):1619-31.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Trinh XB, van Dam PA, Dirix LY, et al.
The rationale for mTOR inhibition in epithelial ovarian cancer. [JOURNAL ARTICLE]
Expert Opin Investig Drugs 2009 Nov 4.
Abstract | Full Citation | Find Related Articles |
| Wood J, Scott E, Thomas AL
Novel VEGF signalling inhibitors: how helpful are biomarkers in their early development? [JOURNAL ARTICLE]
Expert Opin Investig Drugs 2009 Oct 30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Amir E, Mandoky L, Blackhall F, et al.
Antivascular agents for non-small-cell lung cancer: current status and future directions. [JOURNAL ARTICLE]
Expert Opin Investig Drugs 2009 Oct 30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Antoniu SA
Discontinued drugs 2008: pulmonary and allergy. [JOURNAL ARTICLE]
Expert Opin Investig Drugs 2009 Oct 23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Carey I, Harrison PM
Monotherapy versus combination therapy for the treatment of chronic hepatitis B. [JOURNAL ARTICLE]
Expert Opin Investig Drugs 2009 Oct 23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Yong HY, Koh MS, Moon A
The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. [JOURNAL ARTICLE]
Expert Opin Investig Drugs 2009 Oct 23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
